724 related articles for article (PubMed ID: 23942292)
21. [Helicobacter pylori eradication for gastric MALT lymphoma].
Nakamura S; Matsumoto T; Kitazono T
Nihon Rinsho; 2013 Aug; 71(8):1424-8. PubMed ID: 23967674
[TBL] [Abstract][Full Text] [Related]
22. Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond.
Montalban C; Norman F
Expert Rev Anticancer Ther; 2006 Mar; 6(3):361-71. PubMed ID: 16503853
[TBL] [Abstract][Full Text] [Related]
23. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
Begum S; Sano T; Endo H; Kawamata H; Urakami Y
J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
[TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas.
Kuo SH; Yeh KH; Wu MS; Lin CW; Hsu PN; Wang HP; Chen LT; Cheng AL
Blood; 2012 May; 119(21):4838-44; quiz 5057. PubMed ID: 22403257
[TBL] [Abstract][Full Text] [Related]
25. Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.
Komoto M; Tominaga K; Nakata B; Takashima T; Inoue T; Hirakawa K
J Exp Clin Cancer Res; 2006 Jun; 25(2):283-5. PubMed ID: 16918142
[TBL] [Abstract][Full Text] [Related]
26. [Gastric MALT lymphoma, a malignancy potentially curable by eradication of Helicobacter pylori].
Delchier JC
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):453-8. PubMed ID: 12700502
[TBL] [Abstract][Full Text] [Related]
27. Gastric mucosal-associated lymphoid tissue lymphoma.
Fischbach W
Gastroenterol Clin North Am; 2013 Jun; 42(2):371-80. PubMed ID: 23639646
[TBL] [Abstract][Full Text] [Related]
28. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
[TBL] [Abstract][Full Text] [Related]
29. De-escalating therapy in gastric aggressive lymphoma.
Cuccurullo R; Govi S; Ferreri AJ
World J Gastroenterol; 2014 Jul; 20(27):8993-7. PubMed ID: 25083073
[TBL] [Abstract][Full Text] [Related]
30. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series.
Fischbach W; Goebeler ME; Ruskone-Fourmestraux A; Wündisch T; Neubauer A; Raderer M; Savio A;
Gut; 2007 Dec; 56(12):1685-7. PubMed ID: 17639089
[TBL] [Abstract][Full Text] [Related]
31. MALT lymphomas: pathogenesis can drive treatment.
Bertoni F; Coiffier B; Salles G; Stathis A; Traverse-Glehen A; Thieblemont C; Zucca E
Oncology (Williston Park); 2011 Nov; 25(12):1134-42, 1147. PubMed ID: 22229204
[TBL] [Abstract][Full Text] [Related]
32. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
[TBL] [Abstract][Full Text] [Related]
33. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
Falcó Jover G; Martínez Egea A; Sánchez Cuenca J; Onrubia Pintado J; García Lafuente N; Ruiz Gómez F; Coronas Planas M
Rev Esp Enferm Dig; 1999 Aug; 91(8):541-8. PubMed ID: 10491486
[TBL] [Abstract][Full Text] [Related]
34. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.
Hong SS; Jung HY; Choi KD; Song HJ; Lee GH; Oh TH; Jo JY; Kim KJ; Byeon JS; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI
Helicobacter; 2006 Dec; 11(6):569-73. PubMed ID: 17083379
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
[TBL] [Abstract][Full Text] [Related]
36. Regression of a primary gastric MALT lymphoma with extensive antrum lesions by Helicobacter pylori eradication.
Cammarota G; Tursi A; Cannizzaro O; Papa A; Cuoco L; Cianci R; Fedeli P; Fedeli G; Gasbarrini G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):361-4. PubMed ID: 9476192
[TBL] [Abstract][Full Text] [Related]
37. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma.
Grünberger B; Wöhrer S; Streubel B; Formanek M; Petkov V; Puespoek A; Haefner M; Hejna M; Jaeger U; Chott A; Raderer M
J Clin Oncol; 2006 Mar; 24(9):1370-5. PubMed ID: 16549831
[TBL] [Abstract][Full Text] [Related]
40. Our experience in Helicobacter pylori infection and gastric MALToma.
Losacco T; Cagiano R; Bottalico L; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Santacroce L
Clin Ter; 2008; 159(4):239-42. PubMed ID: 18776980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]